Efficacy and safety of the first and repeated intradetrusor injections of abobotulinum toxin A 750 U for treating neurological detrusor overactivity
Crossref DOI link: https://doi.org/10.1007/s00345-015-1666-5
Published Online: 2015-08-18
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Peyronnet, Benoit
Roumiguié, Mathieu
Castel-Lacanal, Evelyne
Guillotreau, Julien
Marque, Philippe
Rischmann, Pascal
Gamé, Xavier
Funding for this research was provided by:
Allergan
Ipsen Fund
Text and Data Mining valid from 2015-08-18